[{"data": {"name": "Anti-phospholipid antibodies, neuroleptic treatment and cardiovascular morbidity", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "E. Leuci", "@type": "Person"}, {"name": "L. Manenti", "@type": "Person"}, {"name": "C. Maggini", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.cambridge.org/core/services/aop-cambridge-core/content/view/2735EA5E7AD1B4977B9E169CC4DE8887/S0007125000233370a.pdf/div-class-title-anti-phospholipid-antibodies-neuroleptic-treatment-and-cardiovascular-morbidity-div.pdf", "encodingFormat": "application/pdf"}, {"@type": "MediaObject", "contentUrl": "http://pdfs.semanticscholar.org/507d/08b853029c1fe5ef1d9bf99ba2dced19822d.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Royal College of Psychiatrists", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1192/bjp.190.1.81", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCmz6ksTuD5ra-CTAe2WpZ688KX-CDecd9y4DvWyW-CRNS4DhfpqM5j", "propertyID": "ISCC"}], "datePublished": "2007-01-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]